登记Id

PA10251

药物名称(英)

atazanavir

通用名称

ATV,ATZ,Atazanavir sulfate,BMS-232632,atazanavir

商品名称

"Latazanavir","Reyataz","Zrivada"

品牌组合

类型(英)

Drug

类型

药品

交叉引用

"BindingDB:13934","Canadian Drugs Product Database:02248610","ChEBI:CHEBI:37924","Chemical Abstracts Service:229975-97-7","ChemSpider:130642","ClinicalTrials.gov:NCT00207948","ClinicalTrials.gov:NCT01073761","ClinicalTrials.gov:NCT01138267","ClinicalTrials.gov:NCT01388543","DrugBank:DB01072","KEGG Drug:D01276","PubChem Compound:148192","PubChem Substance:46508504","PubChem Substance:725881","Therapeutic Targets Database:DNC000332","URL:http://en.wikipedia.org/wiki/Atazanavir"

简化分子线性输入规范

CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC

键

InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1

剂量指南

Yes

外部词汇

"MeSH:C413408(atazanavir)","ATC:J05AE08(atazanavir)","ATC:J05AR15(atazanavir and cobicistat)","UMLS:C1145759(Atazanavir)

RxNorm 标识符

343047

ATC 标识符

"J05AE08","J05AR15"

化合物标识符

148192